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Context: Induction of labour is a useful obstetric intervention, yet it is underutilized in Africa. Recommendations for practice 
may reduce its unmet need.
Objective: This study aims to determine labour induction success rates and identify predictors of outcome.
Study Design, Setting and Patients: This was a retrospective, descriptive, cross‑sectional study of 104 women who had 
induction of labour at the University College Hospital, Nigeria.
Main Outcome Measures: Primary outcomes were vaginal delivery within 24 hours and caesarean delivery. Analyses were 
done by Chi‑square tests, t‑tests and logistic regression.
Results: Labour induction rate was 12.7%; most were performed on account of post‑dated pregnancies and pre‑labour 
rupture of membranes. Forty‑six, (44.2%) had vaginal delivery within 24 hours whereas induction failed (i.e. caesarean 
delivery) in 38 (36.5%). The mean duration of the process was 12.0 ± 6.6 hours with misoprostol, 8 hours less than with 
oxytocin (P < 0.01). Misoprostol was significantly more likely to result in delivery within 24 hours in comparison to extra‑amniotic 
transcervical catheter for ripening (P = 0.02, OR = 5.1, 95% CI = 1.2–21.1), and to oxytocin for induction (P = 0.03, OR = 6.5, 
95% CI = 1.2–36.3), respectively. Adverse effects were infrequent and comparable with either method.
Conclusion: Success rate needs to be improved upon. Higher parity, later gestation and misoprostol ripening or induction 
are associated with successful outcomes. It is recommended that clients’ experience may be improved by commencing 
misoprostol cervical ripening the night before induction and administering the medication orally rather than vaginally.
Key words: Induction of labour; intervention; outcome; predictor of success.
Introduction
Induction of labour (IOL) is the process of artificially 
creating uterine contractions with the aim of achieving 
a vaginal delivery. It is a common obstetric intervention; 
prevalence was 23.2% of deliveries in the US in 2011;[1] 
however, it is underutilized in Africa at 4.4%, with an 
unmet need of 66.0–80.2%.[2] It accounts for 6.3% of 
deliveries in Nigeria.[2] It is commonly indicated in 
prevention of prolonged pregnancy, pre‑labour rupture 
of membranes after 34 weeks, intrauterine foetal death, 
placental abruption, chorioamnionitis and hypertensive 
disorders.[3,4] It may be selectively offered on maternal 
request in exceptional circumstances and in births following 
previous caesarean sections. It has been employed in 
women with diabetes in pregnancy, twin gestation, foetal 
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macrosomia, oligohydramnios and maternal cardiac disease; 
however, current evidence is insufficient to recommend 
these indications.[5,6] It is generally not recommended 
for cases of breech presentation, severe foetal growth 
restriction with foetal compromise, or suspected foetal 
macrosomia.[3]
Oxytocin is the most common agent used for induction 
of labour.[7] Prostaglandins E1 (misoprostol) and E2 
(dinoprostone) are also commonly used, both for cervical 
ripening and labour induction. Oral misoprostol was 
found to be as effective as the vaginal regimen, and was 
preferred on account of less risk of ascending infection 
and less need for the intensive monitoring required for 
the vaginal route.[8]
The cervix is considered ripe at a Bishop score of 8,[3,4] 
implying that an unripe cervix would score 7 or less. However, 
most clinical trials use cut‑off scores of 6 and less;[4] and 
most clinicians will ripen the cervix with the latter scores. 
In addition to the medications earlier discussed, mechanical 
means such as osmotic dilators and extra‑amniotic 
transcervical catheters are used. Catheters are as efficacious 
as pharmacological methods and may offer the added 
advantage of less likelihood of contraction abnormalities, 
less discomfort, less cost and being useful for outpatient 
ripening.[9] A Nigerian study comparing catheter ripening to 
50 mcg of vaginal misoprostol found similar success rates in 
both, and shorter ripening duration and lesser oxytocin need 
with misoprostol.[10]
The study centre’s protocol has changed severally over 
recent years with regards to methods of cervical ripening 
and labour induction, dosing protocols and timing. Catheter 
ripening was performed previously for all suitable patients 
until misoprostol became available. Misoprostol use was 
commenced with high‑dose regimens, until lower doses 
appeared to be more suitable. Catheters for ripening 
are inserted in the evening, so that labour induction can 
commence early in the morning and interventions can be 
done during active work hours, if indicated. In order to 
pre‑empt the risk of inadvertent labour stimulation during 
the night, misoprostol ripening is commenced in the 
morning. The demerit of this is that labour induction may 
not commence until late in the day, and the parturient will 
not benefit from daytime interventions. These considerations 
have prompted this formal assessment of the process.
The aim of the study is to determine success rates and identify 
predictors of successful outcomes to make recommendations 
for practice, which may hopefully reduce the unmet need for 
induction of labour.
Materials and Methods
It was a retrospective, cross‑sectional, descriptive study of 
all inductions of labour carried out over a 4‑month period at 
the labour ward of the University College Hospital, Ibadan, 
Nigeria. Approval was obtained from the State Ethical Review 
Committee.
Routine practice of the facility is outlined as follows. Patients 
for elective induction of labour are booked on the list for the 
elective days—Mondays, Wednesdays and Fridays (which 
alternate with the elective Caesarean section days of Tuesdays 
and Thursdays). Blood for possible transfusion is made 
available for them in the blood bank and patients are fasted 
overnight. Bishop score is estimated and cervical ripening is 
performed if score is less than 7. When misoprostol is used as 
the primary ripening agent, it is commenced in the morning 
for elective inductions, at a low dose of 25 mcg 6 hourly. 
Mid‑trimester inductions may be initiated with 6 hourly 
doses as high as 200–400 mcg. Some patients are planned for 
induction with misoprostol; others may go into active labour 
while undergoing cervical ripening with misoprostol. The 
latter do not require oxytocin, and are grouped as induction 
by misoprostol in this study. Oxytocin is not commenced 
until 6 hours after the last misoprostol dose was given. When 
extra‑amniotic transcervical catheter is used for ripening, it 
is passed by the unit registrar the evening before induction, 
and it is expected to fall out spontaneously. If this does not 
happen after 24 hours, the catheter is removed and the cervix 
is re‑assessed. If the cervix is yet unripe, misoprostol may 
be administered instead. Amniotomy is performed at the 
earliest opportunity during induction, when the membranes 
are accessible and the presenting part is well applied to the 
cervix.
A high‑dose protocol is used for oxytocin induction,[11] in which 
2 or 4 U of oxytocin (depending on whether the parturient is 
multiparous or nulliparous, respectively) is added to 500 ml 
of normal saline to run at 15 drops per minute. This gives an 
initial rate of 4 or 8 mU/min, respectively, which is doubled 
every 30 minutes until the contractions are adequate—three 
strong contractions in ten minutes, lasting 45–60 seconds 
each. Urgent inductions are performed at any time when 
indicated, without prior preparation.
Based on a caesarean section rate of 6% in a Nigerian trial 
of cervical ripening methods by Adeniji et al.[10] minimum 
sample size was calculated to be 87. All women who were 
listed consecutively in the register as having had induction 
of labour were identified and their medical records were 
retrieved. This was done until the sample size was achieved, 
covering a 4‑month period from January to April 2014. A data 
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collection tool was employed to retrieve demographic details, 
obstetric features, indications, method and duration of the 
induction of labour, as well as the outcome. The explanatory 
variables were the obstetric and demographic characteristics 
and the method of ripening or induction of labour. The 
primary outcomes were caesarean delivery (indicating that 
the intervention failed) and vaginal delivery within 24 hours, 
whereas secondary outcomes were the duration of labour, 
the need for analgesia and the occurrence of complications 
in the mother or the neonate.
Data were cleaned, entered into a spreadsheet and imported 
into IBM® SPSS® Statistics 20 (IBM Corp, Armonk, USA). 
Analyses were performed with Chi‑square test for categorical 
variables and students’ t‑test for continuous variables. 
Multivariate analysis was carried out with logistic regression. 
P was set at <0.05.
Results
One hundred and four cases of induction of labour were 
reviewed over the study period. The total number of deliveries 
in the study hospital over the same period was 819, giving 
an induction rate of 12.7%. The demographic data of the 
study participants are depicted in Table 1. The participants 
mean age was 31.2 ± 4.8 years. Table 2 shows their obstetric 
characteristics. Thirteen women (12.5%) had undergone a 
previous induction of labour. Most of the participants were 
nulliparous, and most inductions were performed for term 
pregnancies. Eight were for mid‑trimester pregnancy losses. 
The indications for induction are outlined in Table 3. Most 
inductions were done on account of post‑dated pregnancies 
and pre‑labour rupture of membranes.
Sixty‑six women (63.5%) had vaginal deliveries, whereas 
38 (36.5%) had caesarean sections. Forty‑six (44.2%) vaginal 
deliveries were done within 24 hours. Eighty‑seven (83.7%) 
had cervical ripening. Most of these ripenings were 
performed with misoprostol [Table]. Misoprostol was typically 
given per vaginam (in 90.9%), whereas 9.1% were given 
sublingual doses. The median number of doses required in 
this study was 2; the mean was 2.4 ± 1.3 doses. The duration 
of ripening ranged from 3–45 (mean: 14.0 ± 8.7) hours. 
On average, it took about the same time to ripen a cervix 
with either misoprostol or an extra‑amniotic transcervical 
catheter. However, the entire process from commencement 
of ripening till delivery was on the average, 5 hours shorter 
with misoprostol, howbeit statistically insignificant [Table 4]. 
On comparison of obstetric features and outcomes, patients 
whose cervixes were ripened with misoprostol were more 
likely to deliver within 24 hours of intervention than those 
who had catheters [Table 5].







Gestational age at induction
Pre‑viable (<28 weeks) 8 (7.7)
Preterm (28‑36 weeks) 20 (23.1)
Term (37‑42 weeks) 72 (69.2)
Bishop score
0‑4 (unripe cervix) 87 (84.5)
5‑6 (moderate) 15 (14.5)
7‑13 (ripe) 1 (1.0)
Method of cervical ripening
Misoprostol 62 (59.6)
Transcervical catheter 19 (18.3)
Both methods 6 (6.9)
Cervical ripening not done 17 (16.3)
Method of induction of labour
Oxytocin 65 (62.5)
Misoprostol 34 (32.7)
No medication required following catheter passage 5 (4.8%) 










Unskilled worker 44 (42.3)
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It took 2–25 (mean 9.9 ± 5.8) hours from commencement of 
induction to delivery of the baby. The failure of induction was 
diagnosed on average after 14.6 ± 12.6 hours. On comparison 
with oxytocin, misoprostol induction was almost 4 hours 
shorter, while the whole duration of intervention was 8.6 hours 
shorter (P < 0.01) [Table 4]. Oxytocin infusion rates ranged 
between 4–128 mU/minute. The modal dose was 16 mU/minute. 
Twenty‑seven (26.0%) women were given analgesics (opioid) 
during the induction. There was no uterine rupture recorded 
in the series. However, 15 (14.4%) developed maternal 
complications such as retained placenta or products, 8 (7.7%); 
postpartum haemorrhage, 3 (2.9%); post‑caesarean wound 
infection, 2 (1.9%) and perineal tears, 2 (1.9%). The babies’ modal 
Apgar scores were 9 and 10, at 1 and 5 minutes, respectively. 
Three (2.9%) were admitted into the Special Care Baby Unit. There 
were no stillbirths (except for those with previously‑diagnosed 
intrauterine foetal death). Grandmultigravid women were less 
likely to have induction by misoprostol [Table 6].
The main study outcomes were put into logistic regression 
models to evaluate associations. When adjusted for age, 
parity, Bishop score, gestational age at induction, misoprostol 
was more likely to result in a vaginal delivery within 
24 hours in comparison to catheter for ripening (P = 0.02, 
OR = 5.1, 95% CI = 1.2–21.1), and in comparison to oxytocin 
for induction (P = 0.03, OR = 6.5, 95% CI = 1.2–36.3), 
respectively. Neither method of cervical ripening or 
induction of labour was statistically associated with eventual 
delivery by caesarean section; however, patients with higher 
parity (P < 0.01, OR = 0.4, 95% CI = 0.2–0.7) and higher 
gestational age at delivery (P = 0.02, OR = 1.20, 95% 
CI = 1.0–1.4) were significantly less likely to end up with a 
caesarean delivery.
Table 3: Indications for induction of labour among study 
participants
Indication N (%)
Prelabour rupture of membranes 27 (26.0)
Post‑date pregnancy 26 (25.0)
Intrauterine foetal death 19 (18.3)
Hypertensive disorders 14 (13.5)
Intrauterine growth restriction/oligohydramnios/abnormal findings 
on foetal surveillance
4 (3.8)
Intrauterine foetal death in previous pregnancy 4 (3.8)
Gestational diabetes mellitus 3 (2.9)
Severe congenital anomalies 2 (1.9)
Sickle cell disease 1 (1.0)
Others 3 (2.9)
Table 4: Comparison of duration of interventions between 
different methods




Transcervical catheter 14.8±11.1 0.94
Misoprostol 15.0±8.7
When the entire 
duration* of the cases 
are considered





When the entire 




*Refers to the duration from commencement of cervical ripening till time of delivery
Table 5: Cervical ripening-comparison of obstetric features 
and outcomes associated with misoprostol and transcervical 
catheter use






0 34 (52.3) 9 (40.9) 0.08
1‑3 27 (41.5) 8 (36.4)
≥4 4 (6.2) 5 (22.7)
Gestational age
Pre‑viable 7 (10.8) 0 (0) 0.08
Preterm 11 (16.9) 8 (36.4)
Term 47 (72.3) 14 (63.6)
Bishop score
Unripe 61 (93.8) 20 (95.2) >0.99
Moderately ripe 4 (6.2) 1 (4.8)
Required oxytocin
Yes 33 (50.8) 15 (68.2) 0.16
No 32 (49.2) 7 (31.8)
Given analgesia
Yes 15 (23.1) 7 (31.8) 0.42
No 50 (76.9) 15 (68.2)
Vaginal delivery within 
24 hours
Yes 30 (73.2) 6 (40.0) 0.02
No 11 (26.8) 9 (60.0)
Delivery by C‑section
Yes 24 (36.9) 7 (31.8) 0.67
No 41 (63.1) 15 (68.2)
Instrumental delivery
Yes 1 (1.6) 0 (0) 0.76
No 62 (98.4) 2 (100.0)
Apgar score at 5 min
0‑6 2 (3.8) 0 (0) >0.99
7‑10 50 (96.2) 12 (100.0)
Neonatal admission
Yes 1 (1.5) 1 (4.8) 0.39
No 64 (98.5) 20 (95.2)
Maternal complications
Yes 9 (13.8) 5 (23.8) 0.32
No 56 (86.2) 16 (76.2)
Bello and Akinyotu: Predictors for successful labour induction
147Tropical Journal of Obstetrics and Gynaecology / May-Aug 2016 / Volume 33 / Issue 2
Discussion
Most of the inductions in the study centre were carried out 
for term (and often post‑dated) pregnancies, yet the cervices 
of most women were unripe at the time of the intervention. 
Cervical ripening is, therefore, an important part of the 
process. Misoprostol was the most common ripening agent 
used. This appears to be an appropriate choice because it 
took 5 hours less than a catheter to ripen a cervix, and was 
5 times more likely to result in a vaginal delivery within 
24 hours. There were no other differences in maternal or 
foetal outcome, or in need for analgesia, or complications, in 
either method. When one method failed to achieve ripening, 
the other method was employed in series—these were 
excluded from the comparison. A relatively newer obstetric 
practice is to apply both methods simultaneously;[12] a pilot 
was being done at the study centre at the time of writing.
Cervical ripening with misoprostol is typically commenced in 
the morning in the study centre because of concerns regarding 
inadequate monitoring if carried out at night, along with the 
possibility of nocturnal labour commencement following 
misoprostol ripening. The average ripening duration of 15 
hours found in this study implies that oxytocin infusion would 
typically commence late at night, which is not desirable. Nature 
appears to generally select spontaneous onset of labour in 
the evening due to circadian rhythm, however, a systematic 
review of labour induction did not find any advantage of either 
timing.[13] The patients in the quoted review preferred morning 
onset to avoid their sleep being disturbed. However, the long 
duration in the index study suggests that ripening should be 
commenced at night, so that oxytocin infusion can commence 
at daytime when it can be adequately supervised.
In comparison to oxytocin as an induction agent in this 
study, misoprostol also appeared to be superior. Labour 
lasted 8 hours less, and was six times more likely to result 
in a vaginal delivery within 24 hours, without any increased 
incidence of adverse outcomes in either group. Oxytocin 
doses at which contractions became adequate were rather 
high in this study, as much as 128 mU/min was given in some 
instances. The average dose was 16 mU/min, which is double 
the usual dose.[14] This may be explained by the heat instability 
of oxytocin; because Nigeria does not enjoy uninterrupted 
power supply, one is unable to ensure that the cold chain is 
not broken at any point until it is used for the patient. This 
results in reduced efficacy of the drug. This further supports 
misoprostol (which does not require refrigeration) use in 
the study area. Neither induction method was significantly 
associated with a caesarean delivery.
All the mid‑trimester inductions were performed with 
misoprostol. This is recommended as the most efficient 
method before 28 weeks,[4] due to the paucity of oxytocin 
receptors on the uterus before then. Misoprostol is mostly 
given vaginally at the study centre. The documented risks of 
frequent vaginal examinations and need for closer monitoring 
may be avoided by adopting the use of the oral route because 
the latter’s effects are comparable.[8] This quoted systematic 
review did not give information on how cervical ripening was 
assessed, seeing that one of the purposes of the oral route 
is to avoid frequent pelvic examinations. In the index study, 
patients required on average two doses of misoprostol before 
ripening was achieved. In the absence of uterine contractions, 
it may be reasonable to administer two doses before a pelvic 
examination is done (that is, after 12 hours).
Induction was less likely to result in a caesarean delivery 
as gestational age and parity increased. This is expected 
because labour is generally more likely to be successful in late 
term (American College of Obstetricians and Gynecologists 
(ACOG) recommends that elective induction should not be 
Table 6: Induction of labour-comparison of obstetric features 
and outcomes between misoprostol and oxytocin






0 20 (58.8) 30 (46.2) 0.01
1‑3 14 (41.2) 22 (33.8)
≥4 0 (0) 13 (20.0)
Gestational age
Pre‑viable 4 (11.8) 3 (4.6) 0.17
Preterm 4 (11.8) 17 (26.2)
Term 26 (76.5) 45 (69.2)
Given analgesia
Yes 6 (17.6) 17 (27.0) 0.30
No 28 (82.4) 46 (73.0)
Vaginal delivery within 
24 hours
Yes 16 (88.9) 29 (63.0) 0.07
No 2 (11.1) 17 (37.0)
Delivery by C‑section
Yes 16 (47.1) 19 (29.2) 0.08
No 18 (52.9) 46 (70.8)
Instrumental delivery
Yes 0 (0) 2 (3.2) 0.43
No 33 (100.0) 61 (96.8)
Apgar score at 5 min
0‑6 1 (3.6) 2 (4.0) >0.99
7‑10 27 (96.4) 48 (96.0)
Neonatal admission
Yes 1 (2.9) 2 (3.1) 0.73
No 33 (97.1) 62 (96.9) 
Maternal complications
Yes 6 (17.6) 12 (18.8) 0.89
No 28 (82.4) 52 (81.2)
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performed before 39 weeks),[4] and women with previous 
deliveries are generally less likely to have dysfunctional labour. 
The risk of caesarean delivery has been shown to be lower 
with elective induction of labour at term than with expectant 
management, without an increased risk of morbidity or 
perinatal mortality.[15] It is the study centre’s practice to induce 
post‑dated pregnancy, rather than manage expectantly.
This study is limited by being a retrospective review rather 
than a prospective trial. It may be difficult to control for 
confounders, which include the reasons for choosing either 
method for labour induction. It is hoped, however, that the 
multivariate analyses have assisted in dismissing some of 
these confounders.
Conclusion
In conclusion, induction of labour success rate needs to be 
improved. Higher parity, later gestation and misoprostol 
use (either for cervical ripening or induction) are associated 
with successful outcomes. It is recommended that clients’ 
experience may be improved by commencing misoprostol 
cervical ripening the night before induction and administering 
the medication orally, rather than vaginally.
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